TRELSTAR Side Effects

7016845-8 | Type 1 Diabetes Mellitus
on Sep 14, 2010 Female patient from MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF , child 9 years of age, was diagnosed with precocious puberty and was treated with Trelstar (View Usage). Patient experienced the following unwanted or unexpected effects: type 1 diabetes mellitus. Trelstar dosage: 3.75 Mg, Monthly. Patient was hospitalized.

7016844-6 | Autoimmune Thyroiditis
Patient was taking Trelstar (View Usage). Patient had the following side effects: autoimmune thyroiditis on Sep 14, 2010 from MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF Additional patient health information: Female patient , child 8 years of age, was diagnosed with precocious puberty and. Trelstar dosage: 3.75 Mg, Monthly.

5730314-4 | Gastrointestinal Haemorrhage, Thrombocytopenia
Adverse event was reported on Apr 21, 2008 by a Male patient taking Trelstar (View Usage) (Dosage: 11.25 Mg Q 12 Weeks, Intramuscular) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: POLAND , 85 years of age, After Trelstar was administered, patient had the following side effects: gastrointestinal haemorrhage, thrombocytopenia. Patient was hospitalized.

5723073-2 | Bone Formation Decreased, Impaired Healing
on Apr 18, 2008 Male patient from UNITED KINGDOM , child 10 years of age, was diagnosed with adrenogenital syndrome and was treated with Trelstar (View Usage). Patient experienced the following unwanted or unexpected effects: bone formation decreased, impaired healing. Trelstar dosage: Intramsucular.


5721088-1 | Transient Ischaemic Attack
on Apr 14, 2008 Female patient from GREECE , 40 years of age, was diagnosed with endometriosis (What is endometriosis?) and was treated with Trelstar (View Usage). Patient had the following side effects: transient ischaemic attack. Trelstar dosage: 11.25 Mg, Intramuscular. Patient was hospitalized.

5689600-9 | Impaired Healing, Resorption Bone Increased
Patient was taking Trelstar (View Usage). After Trelstar was administered, patient had the following side effects: impaired healing, resorption bone increased on Mar 19, 2008 from UNITED KINGDOM Additional patient health information: Male patient , child 10 years of age, was diagnosed with adrenogenital syndrome and. Trelstar dosage: Intramuscular.

5623936-2 | Angioedema, Chills, Hot Flush
Adverse event was reported on Jan 29, 2008 by a Male patient taking Trelstar (View Usage) (Dosage: 11.25mg, Q 3 Months, Intramuscular) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: FRANCE , 64 years of age, Patient experienced the following unwanted or unexpected effects: angioedema, chills, hot flush.

5607629-3 | Blood Pressure Systolic Increased, Gamma-glutamyltransferase Increased, Headache, Hyperviscosity Syndrome, Macular Oedema, Retinal Vein Thrombosis, Tinnitus, Vision Blurred, Visual Acuity Reduced
on Jan 17, 2008 Male patient from FRANCE , 56 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trelstar (View Usage). Patient had the following side effects: blood pressure systolic increased, gamma-glutamyltransferase increased, headache (What is headache?), hyperviscosity syndrome, macular oedema, retinal vein thrombosis, tinnitus (What is tinnitus?), vision blurred, visual acuity reduced. Trelstar dosage: 11.25 Mg, Every 3 Months, Intramuscular. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

5599353-0 | Neuralgia, Paraesthesia, Subcutaneous Nodule
on Jan 08, 2008 Male patient from FRANCE , 77 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trelstar (View Usage). After Trelstar was administered, patient had the following side effects: neuralgia, paraesthesia, subcutaneous nodule. Trelstar dosage: 11.25 Mg, Once (1 In 3 Months), Subcutaneous.

5515870-3 | Condition Aggravated, Endometriosis, Metrorrhagia
Patient was taking Trelstar (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, endometriosis (What is endometriosis?), metrorrhagia on Nov 02, 2007 from FRANCE Additional patient health information: Female patient , 28 years of age, was diagnosed with endometriosis (What is endometriosis?) and. Trelstar dosage: 11.25 Mg, Q 3 Months, Intramuscular. During the same period patient was treated with YASMIN (View Yasmin Review and Yasmin Label ). Patient was hospitalized.

5444592-2 | Porphyria Non-acute
Adverse event was reported on Aug 23, 2007 by a Male patient taking Trelstar (View Usage) (Dosage: Parenteral) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: NETHERLANDS , 49 years of age, Patient had the following side effects: porphyria non-acute.

5401989-4 | Burning Sensation, Decreased Appetite, Glossodynia, Insomnia, Mouth Ulceration, Oral Discomfort, Oral Intake Reduced, Oral Pain
on Jul 19, 2007 Female patient from FRANCE , 43 years of age, was diagnosed with endometriosis (What is endometriosis?) and was treated with Trelstar (View Usage). After Trelstar was administered, patient had the following side effects: burning sensation, decreased appetite, glossodynia, insomnia, mouth ulceration, oral discomfort, oral intake reduced, oral pain. Trelstar dosage: 11.25 Mg, 1 Q3 Months, Intramsucular. Patient was hospitalized.

5397291-X | Asthenia, Blood Lactate Dehydrogenase Increased, Dyspnoea, Haemolytic Anaemia, Macrocytosis, Marrow Hyperplasia
on Jul 10, 2007 Male patient from FRANCE , 79 years of age, weighting 154.3 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trelstar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood lactate dehydrogenase increased, dyspnoea, haemolytic anaemia, macrocytosis, marrow hyperplasia. Trelstar dosage: 11.25 Mg, Single, Intramuscular. During the same period patient was treated with ZOXAN LP (1 Dose Form, Daily, Oral) (View Zoxan Lp Review and Zoxan Lp Label ), DAFLON (DIOSMIN) (View Daflon (diosmin) Review and Daflon (diosmin) Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), NIFUROXAZIDE (NIFUROXAZIDE) (View Nifuroxazide (nifuroxazide) Review and Nifuroxazide (nifuroxazide) Label ), ESBERIVEN (RUTOSIDE, MELILOT) (View Esberiven (rutoside, Melilot) Review and Esberiven (rutoside, Melilot) Label ). Patient was hospitalized.

5382271-0 | Kidney Transplant Rejection
Patient was taking Trelstar (View Usage). Patient had the following side effects: kidney transplant rejection on Jun 22, 2007 from FRANCE Additional patient health information: Female patient , 40 years of age, . Trelstar dosage: 11.25 Mg, 1 In 3 M, Intramuscular. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), ELISOR (View Elisor Review and Elisor Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

5369919-1 | Blood Albumin Decreased, Blood Bilirubin Increased, Blood Bilirubin Unconjugated Increased, Blood Sodium Decreased, Bone Lesion, Colonic Polyp, Duodenitis, Fatigue, Gastritis
Adverse event was reported on Jun 19, 2007 by a Male patient taking Trelstar (View Usage) (Dosage: 15 Mg, Every 4 Months, Intramuscular) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: SOUTH AFRICA , 69 years of age, After Trelstar was administered, patient had the following side effects: blood albumin decreased, blood bilirubin increased, blood bilirubin unconjugated increased, blood sodium decreased, bone lesion, colonic polyp (What is colonic polyp?), duodenitis, fatigue, gastritis. Patient was hospitalized.

5361287-4 | Pulmonary Embolism
on Jun 07, 2007 Female patient from FRANCE , 25 years of age, weighting 220.5 lb, was diagnosed with endometriosis (What is endometriosis?), prophylaxis and was treated with Trelstar (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Trelstar dosage: 11.25 Mg, Single Inj 1 In 3 Mos., Intramuscular. During the same period patient was treated with ADEPAL(ETHINYLESTRADIOL) (150 Mcg / 20 Mcg (1 In 1 Day), Oral) (View Adepal(ethinylestradiol) Review and Adepal(ethinylestradiol) Label ). Patient was hospitalized.

5339419-3 | Pulmonary Embolism
on May 18, 2007 Female patient from UNITED STATES , 25 years of age, was diagnosed with endometriosis (What is endometriosis?), prophylaxis and was treated with Trelstar (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Trelstar dosage: 11.25 Mg, 1 In 3 Months, Intramuscular. During the same period patient was treated with MERCILON (ETHINYLESTRADIOL) (150 Mcg / 20 Mcg (1 In 1 Day), Oral) (View Mercilon (ethinylestradiol) Review and Mercilon (ethinylestradiol) Label ). Patient was hospitalized.

5319699-0 | Pulmonary Embolism
Patient was taking Trelstar (View Usage). After Trelstar was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?) on Apr 30, 2007 from FRANCE Additional patient health information: Female patient , 25 years of age, was diagnosed with endometriosis (What is endometriosis?), prophylaxis and. Trelstar dosage: 11.25 Mg, 1 In 3 Months, Intramuscular. During the same period patient was treated with ORAL CONTRACEPTIVES NOS (ORAL CONTRACEPTIVE NOS) (Oral) (View Oral Contraceptives Nos (oral Contraceptive Nos) Review and Oral Contraceptives Nos (oral Contraceptive Nos) Label ). Patient was hospitalized.

5262270-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Jaundice, Transaminases Increased
Adverse event was reported on Mar 05, 2007 by a Male patient taking Trelstar (View Usage) (Dosage: 11.25 Mg, 1 In 3 Months, Intramuscular) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: FRANCE , 74 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, jaundice (What is jaundice?), transaminases increased. During the same period patient was treated with LIPANTHYL ^BRISTOL MYERS SQUIBB^ (FENOFIBRATE) (View Lipanthyl ^bristol-myers Squibb^ (fenofibrate) Review and Lipanthyl ^bristol-myers Squibb^ (fenofibrate) Label ), LIORESAL (View Lioresal Review and Lioresal Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), CHRONADALATE (View Chronadalate Review and Chronadalate Label ), LYRICA (View Lyrica Review and Lyrica Label ), KARDEGIC (ACETYLSALICYLATE LYSINE) (View Kardegic (acetylsalicylate Lysine) Review and Kardegic (acetylsalicylate Lysine) Label ). Patient was hospitalized.

5255835-2 | Blood Testosterone Increased, Condition Aggravated, Tachyphylaxis, Therapeutic Response Decreased
on Feb 26, 2007 Male patient from FRANCE , child 9 years of age, weighting 74.96 lb, was diagnosed with precocious puberty, epilepsy (What is epilepsy?) and was treated with Trelstar (View Usage). Patient had the following side effects: blood testosterone increased, condition aggravated, tachyphylaxis, therapeutic response decreased. Trelstar dosage: See Image. During the same period patient was treated with DEPAKENE (Oral) (View Depakene Review and Depakene Label ). Patient was hospitalized.

5255833-9 | Deafness Unilateral, Inner Ear Disorder, Ischaemia, Vertigo, Vestibular Disorder
on Feb 19, 2007 Female patient from FRANCE , 54 years of age, was diagnosed with fibroma and was treated with Trelstar (View Usage). After Trelstar was administered, patient had the following side effects: deafness unilateral, inner ear disorder, ischaemia, vertigo, vestibular disorder. Trelstar dosage: 11.25 Mg, 1 In 3 Months, Intramuscular.

5246237-3 | Pyelonephritis, Unintended Pregnancy
Patient was taking Trelstar (View Usage). Patient experienced the following unwanted or unexpected effects: pyelonephritis, unintended pregnancy on Feb 05, 2007 from FRANCE Additional patient health information: Female patient , 21 years of age, was diagnosed with endometriosis (What is endometriosis?) and. Trelstar dosage: 11.25 Mg. Q3 Months, Intramuscular.

5236488-6 | Blood Phosphorus Increased, Calcinosis, Corneal Deposits
Adverse event was reported on Feb 05, 2007 by a Male patient taking Trelstar (View Usage) (Dosage: 11.25 Mg, Intramuscular) was diagnosed with prostate cancer metastatic and. Location: BELGIUM , 86 years of age, Patient had the following side effects: blood phosphorus increased, calcinosis, corneal deposits.

5209496-9 | Dizziness, Dysphagia, Erythema Multiforme, Feeling Hot, Rash, Scab, Skin Exfoliation
on Jan 03, 2007 Female patient from UNITED STATES , 48 years of age, was diagnosed with ovarian disorder and was treated with Trelstar (View Usage). After Trelstar was administered, patient had the following side effects: dizziness (What is dizziness?), dysphagia, erythema multiforme, feeling hot, rash (What is rash?), scab (What is scab?), skin exfoliation. Trelstar dosage: . During the same period patient was treated with EXEMESTANE (View Exemestane Review and Exemestane Label ). Patient was hospitalized.

5189615-3 | Ovarian Hyperstimulation Syndrome
on Dec 06, 2006 Female patient from FRANCE , 28 years of age, was diagnosed with in vitro fertilisation and was treated with Trelstar (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian hyperstimulation syndrome. Trelstar dosage: 1.5 Mg (1.5mg, 1 In 28 D), Intramuscular. During the same period patient was treated with GONAL F (See Image) (View Gonal-f Review and Gonal-f Label ), GONAL F (See Image) (View Gonal-f Review and Gonal-f Label ). Patient was hospitalized.

5081610-8 | Acute Pulmonary Oedema, Asthenia, Cardiac Failure, Headache, Hypertensive Crisis, Vertigo
Patient was taking Trelstar (View Usage). Patient had the following side effects: acute pulmonary oedema, asthenia, cardiac failure, headache (What is headache?), hypertensive crisis, vertigo on Aug 04, 2006 from FRANCE Additional patient health information: Male patient , 73 years of age, was diagnosed with prostate cancer metastatic and. Trelstar dosage: 11.25 Mg Q 3 Months, Intramuscular. During the same period patient was treated with CIPRALAN (View Cipralan Review and Cipralan Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), ICAZ (ISRADIPINE) (View Icaz (isradipine) Review and Icaz (isradipine) Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), KARDEGIC (ACETYLSLICYLATE LYSINE) (View Kardegic (acetylslicylate Lysine) Review and Kardegic (acetylslicylate Lysine) Label ), PROZAC (View Prozac Review and Prozac Label ).

4956257-1 | Hepatic Failure, Hepatitis Cholestatic
Adverse event was reported on Mar 20, 2006 by a Male patient taking Trelstar (View Usage) (Dosage: Intramuscular) was diagnosed with prostate cancer (What is prostate cancer?), hypertension and. Location: SPAIN , 83 years of age, After Trelstar was administered, patient had the following side effects: hepatic failure, hepatitis cholestatic. During the same period patient was treated with PROSTACUR (FLUTAMIDE) (Oral) (View Prostacur (flutamide) Review and Prostacur (flutamide) Label ), NICARDIPINE (NICARDIPINE) (Oral) (View Nicardipine (nicardipine) Review and Nicardipine (nicardipine) Label ). Patient was hospitalized.

4930814-0 | Myocardial Infarction
on Feb 16, 2006 Female patient from IRELAND , 35 years of age, was treated with Trelstar (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Trelstar dosage: 11.25 Mg, Q 3 Mo, Intramuscular. Patient was hospitalized.

4897047-8 | Immune System Disorder, Polymyositis
on Jan 16, 2006 Male patient from GERMANY , 74 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trelstar (View Usage). Patient had the following side effects: immune system disorder, polymyositis. Trelstar dosage: 11.25 Mg, Single, Intramuscular. During the same period patient was treated with CSE INHIBITOR NOS (View Cse Inhibitor Nos Review and Cse Inhibitor Nos Label ), ATI BLOCKER NOS (View Ati Blocker Nos Review and Ati Blocker Nos Label ). Patient was hospitalized.

4896331-1 | Coagulopathy, Gastrointestinal Haemorrhage, Haemoglobin Decreased, Hepatic Encephalopathy, Hepatitis Fulminant, Hepatorenal Syndrome, Hypotension, International Normalised Ratio Increased
Patient was taking Trelstar (View Usage). After Trelstar was administered, patient had the following side effects: coagulopathy, gastrointestinal haemorrhage, haemoglobin decreased, hepatic encephalopathy, hepatitis fulminant, hepatorenal syndrome, hypotension, international normalised ratio increased on Jan 20, 2006 from PORTUGAL Additional patient health information: Male patient , 85 years of age, was diagnosed with neoplasm prostate and. Trelstar dosage: 11.25 Mg Q 3 Months X 2 Total, Intramuscular. During the same period patient was treated with CYPROTERONE ACETATE(CYPROTERONE ACETATE) (100 Mg, Daily, Oral) (View Cyproterone Acetate(cyproterone Acetate) Review and Cyproterone Acetate(cyproterone Acetate) Label ).

4882348-X | Device Failure, Hot Flush, Therapeutic Response Decreased, Threatened Labour, Unintended Pregnancy
Adverse event was reported on Jan 03, 2006 by a Female patient taking Trelstar (View Usage) (Dosage: 11.25 Mg, Every 3 Months, Intramuscular) was diagnosed with endometriosis (What is endometriosis?) and. Location: FRANCE , 24 years of age, weighting 123.5 lb, Patient experienced the following unwanted or unexpected effects: device failure, hot flush, therapeutic response decreased, threatened labour, unintended pregnancy. Patient was hospitalized.

4882337-5 | Asthenia, Blood Creatine Phosphokinase Increased, Myalgia, Oedema Peripheral
on Jan 03, 2006 Male patient from GERMANY , 74 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trelstar (View Usage). Patient had the following side effects: asthenia, blood creatine phosphokinase increased, myalgia, oedema peripheral. Trelstar dosage: 11.25 Mg, Single, Intramuscular. Patient was hospitalized.

4745201-8 | Hepatitis
on Aug 02, 2005 Male patient from SPAIN , 68 years of age, was diagnosed with prostate cancer (What is prostate cancer?), bladder cancer (What is bladder cancer?), bronchitis chronic and was treated with Trelstar (View Usage). After Trelstar was administered, patient had the following side effects: hepatitis (What is hepatitis?). Trelstar dosage: 11.25 Mg, Intramuscular. During the same period patient was treated with CASODEX (50mg, Daily, Oral) (View Casodex Review and Casodex Label ), CEMIDON B6 (ISONIAZID, PYRIDOXINE HYDROCHLORIDE) (Oral) (View Cemidon B6 (isoniazid, Pyridoxine Hydrochloride) Review and Cemidon B6 (isoniazid, Pyridoxine Hydrochloride) Label ), AUGMENTIN '125' (Oral) (View Augmentin '125' Review and Augmentin '125' Label ).

4744624-0 | Anaphylactic Shock, Loss Of Consciousness, Throat Tightness, Urticaria
Patient was taking Trelstar (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, loss of consciousness, throat tightness, urticaria on Jun 19, 2005 from UNITED STATES Additional patient health information: Male patient , 50 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Trelstar dosage: 11.25 Mg, Single, Intramuscular. Patient was hospitalized.

4735057-1 | Cerebrovascular Accident
Adverse event was reported on Jul 22, 2005 by a Male patient taking Trelstar (View Usage) (Dosage: 11.25 Mg, Single, Intramuscular) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 74 years of age, weighting 216.1 lb, Patient had the following side effects: cerebrovascular accident. During the same period patient was treated with PROBENECID TABLET (View Probenecid Tablet Review and Probenecid Tablet Label ), COUMADIN (View Coumadin Review and Coumadin Label ), DIOVANE (VALSARTAN) (View Diovane (valsartan) Review and Diovane (valsartan) Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LOTREL (View Lotrel Review and Lotrel Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), TYLENOL (View Tylenol Review and Tylenol Label ). Patient was hospitalized.

4616017-8 | Bone Marrow Depression, Pancytopenia
on Mar 10, 2005 Female patient from , child 9 years of age, was diagnosed with precocious puberty and was treated with Trelstar (View Usage). After Trelstar was administered, patient had the following side effects: bone marrow depression, pancytopenia. Trelstar dosage: 11.25 Mg, Every 3 Months, Intramuscular.

4553270-3 | Antinuclear Antibody Positive, Hepatitis, Insomnia, Toxocariasis
on Jan 06, 2005 Male patient from , 64 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Trelstar (View Usage). Patient experienced the following unwanted or unexpected effects: antinuclear antibody positive, hepatitis (What is hepatitis?), insomnia, toxocariasis. Trelstar dosage: 11.25 Mg 91/3 Months), Intramuscular. Patient was hospitalized.